Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |